Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
PSE-304
Phase 3 small_molecule completed
Quick answer
Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets for Contraception is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Contraception
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed